Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
MR22 is an inhibitor of salt-inducible kinase (SIK; IC50s = 72, 89, and 18 nM for SIK1, SIK2, and SIK3, respectively).1 It is selective for SIK1-SIK3 over EPHA1-EPHA4 (IC50s = 0.145-2.1 µM), EPHB1-EPHB4 (IC50s = 0.607-22.6 µM), Abl1 (IC50 = 28.1 µM), JNK1 (IC50 = 23.2 µM), GAK (IC50 = 33.8 µM), and RSK1B (IC50 = >45 µM). MR22 (5 µM) induces cell cycle arrest at the G1 phase and reduces rapamycin-induced Akt phosphorylation in SKOV3 ovarian cancer cells.
WARNING This product is not for human or veterinary use.
1. Shifting the selectivity of pyrido[2,3-